Compile Data Set for Download or QSAR
Report error Found 484 Enz. Inhib. hit(s) with all data for entry = 2103
TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338005(US9751854, Compound I-181 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338006(US9751854, Compound I-182 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338003(US9751854, Compound I-179 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338263(US9751854, Compound I-447 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338009(US9751854, Compound I-185 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338269(US9751854, Compound I-454 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338007(US9751854, Compound I-183 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337997(US9751854, Compound I-173 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337998(US9751854, Compound I-174 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338257(US9751854, Compound I-441 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM352593(US9802960, Compound I-171)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338002(US9751854, Compound I-178 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338282(US9751854, Compound I-467 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338019(US9751854, Compound I-195 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338020(US9751854, Compound I-196 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338025(US9751854, Compound I-201 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338023(US9751854, Compound I-199 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338024(US9751854, Compound I-200 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338011(US9751854, Compound I-187 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338271(US9751854, Compound I-456 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338277(US9751854, Compound I-463 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338039(US9751854, Compound I-214 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338036(US9751854, Compound I-211 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338042(US9751854, Compound I-217 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338301(US9751854, Compound I-486 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338030(US9751854, Compound I-206 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338027(US9751854, Compound I-203 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338028(US9751854, Compound I-204 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338032(US9751854, Compound I-207 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338054(US9751854, Compound I-229 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338053(US9751854, Compound I-228 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338304(US9751854, Compound I-490 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338050(US9751854, Compound I-225 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM352660(US9802960, Compound I-238)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338064(US9751854, Compound I-239 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM352426(US9802960, Compound I-5)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM352681(US9802960, Compound I-259)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337827(US9751854, Compound I-10 | US9802960, Compound I-1...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337824(US9751854, Compound I-7 | US9802960, Compound I-7)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338088(US9751854, Compound I-264 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338089(US9751854, Compound I-265 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337817(US9751854, Compound I-1 | US9802960, Compound I-1)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338080(US9751854, Compound I-255 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338100(US9751854, Compound I-276 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338099(US9751854, Compound I-275 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM338106(US9751854, Compound I-282 | US9802960, Compound I-...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337840(US9751854, Compound I-23 | US9802960, Compound I-2...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337841(US9751854, Compound I-24 | US9802960, Compound I-2...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337828(US9751854, Compound I-11 | US9802960, Compound I-1...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM337829(US9751854, Compound I-12 | US9802960, Compound I-1...)
Affinity DataIC50: 10nMAssay Description:100 nL compounds in DMSO are added to wells of a 384 well microtitre plate (Greiner 780076). At room temperature: 5 ul VPS34 reaction buffer (Invitro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

Displayed 1 to 50 (of 484 total ) | Next | Last >>
Jump to: